Skip to main content
Top
Published in: Metabolic Brain Disease 5/2021

01-06-2021 | Autism Spectrum Disorder | Original Article

Association between autism spectrum disorder and polymorphisms in genes encoding serotine and dopamine receptors

Authors: Jun Liu, Huamei Fu, Jiangying Kong, Hong Yu, Zengyu Zhang

Published in: Metabolic Brain Disease | Issue 5/2021

Login to get access

Abstract

Dysfunctions of the neurotransmitter system are related to the development of many psychological diseases including autism spectrum disorder (ASD). Single nucleotide polymorphisms (SNPs) are correlated with varied susceptibility of ASD and response to treatments. The association between SNPs in genes encoding serotonin and dopamine receptors and childhood ASD was examined in a Chinese Han population. Both autistic children (n = 319) and age-and gender-matched healthy controls (n = 347) were recruited from a local district. Disease severity was evaluated by the childhood autism rating scale (CARS). SNPs of rs6311 and rs6313 in the serotonin receptor HTR2A gene, rs4630328 in the dopamine receptor D2 (DRD2) gene and rs167771 in the DRD3 gene were examined. The CC genotype of rs6311 was significantly associated with an increased risk of ASD (odds ratio (OD) = 1.8 vs TT, 95% confidence interval (CI): 1.2–2.8, P = 0.0085). Carriers of the C allele of rs6311 had a significantly higher risk of childhood ASD (OD =1.3, 95% CI = 1.1–1.7, P = 0.0094). A strong linkage disequilibrium was observed between rs6311 and rs6313 (D′ = 0.93, r2 = 0.86). There were significant correlations between haplotypes (T-A and C-G of rs6311-rs6313) and risk of childhood ASD. In contrast, the frequencies of genotypes and alleles of rs6313, rs4630328 and rs167771 were not significantly different between the case and control groups. All the SNPs examined were not associated with severity of the disease. Our study demonstrates that certain SNPs in the HTR2A gene, but not the DRD2 and DRD3, are associated with susceptibility to childhood ASD.
Literature
go back to reference Kolevzon A, Mathewson KA, Hollander E (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67:407–414CrossRef Kolevzon A, Mathewson KA, Hollander E (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67:407–414CrossRef
go back to reference Toma C, Hervás A, Balmaña N, Salgado M, Maristany M, Vilella E, Aguilera F, Orejuela C, Cuscó I, Gallastegui F, Pérez-Jurado LA, Caballero-Andaluz R, Diego-Otero Y, Guzmán-Alvarez G, Ramos-Quiroga JA, Ribasés M, Bayés M, Cormand B (2013) Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC. World J Biol Psychiatry 14:516–527. https://doi.org/10.3109/15622975.2011.602719CrossRefPubMed Toma C, Hervás A, Balmaña N, Salgado M, Maristany M, Vilella E, Aguilera F, Orejuela C, Cuscó I, Gallastegui F, Pérez-Jurado LA, Caballero-Andaluz R, Diego-Otero Y, Guzmán-Alvarez G, Ramos-Quiroga JA, Ribasés M, Bayés M, Cormand B (2013) Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC. World J Biol Psychiatry 14:516–527. https://​doi.​org/​10.​3109/​15622975.​2011.​602719CrossRefPubMed
Metadata
Title
Association between autism spectrum disorder and polymorphisms in genes encoding serotine and dopamine receptors
Authors
Jun Liu
Huamei Fu
Jiangying Kong
Hong Yu
Zengyu Zhang
Publication date
01-06-2021
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 5/2021
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-021-00699-3

Other articles of this Issue 5/2021

Metabolic Brain Disease 5/2021 Go to the issue